Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Pyxis Oncology (PYXS) Net Margin (2024 - 2025)

Historic Net Margin for Pyxis Oncology (PYXS) over the last 2 years, with Q2 2025 value amounting to 650.85%.

  • Pyxis Oncology's Net Margin changed N/A to 650.85% in Q2 2025 from the same period last year, while for Sep 2025 it was 3461.03%, marking a year-over-year change of. This contributed to the annual value of 478.95% for FY2024, which is N/A changed from last year.
  • As of Q2 2025, Pyxis Oncology's Net Margin stood at 650.85%.
  • Over the past 5 years, Pyxis Oncology's Net Margin peaked at 24.8% during Q1 2024, and registered a low of 650.85% during Q2 2025.